Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Artificial Intelligence (AI)-Powered Pathology Analysis System Market Expected To Reach $322.65 Billion By 2030 At 9.4% CAGR
The artificial intelligence (AI)-powered pathology analysis system market has experienced significant expansion in recent years. This market is projected to increase from $66.06 billion in 2025 to $78.02 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 18.1%. The growth observed historically stems from elements like the rising incidence of chronic and infectious diseases leading to heightened diagnostic demand, the worldwide development of hospital and laboratory infrastructure, the growing incorporation of digital imaging into pathology workflows, a lack of skilled pathologists across many regions, and the emergence of basic computer-assisted diagnostic tools in healthcare.
The artificial intelligence (AI)-powered pathology analysis system market is set to experience rapid expansion over the next few years, with projections indicating a growth to $153.02 billion by 2030, driven by a compound annual growth rate (CAGR) of 18.3%. This significant increase in the forecast period can be attributed to several factors: advancements in AI and deep learning algorithms for medical image analysis, the widening application of precision medicine and genomics-driven diagnostics, the growing adoption of cloud-based healthcare data ecosystems, the expansion of telepathology and remote diagnostic services, and a rising commitment to investing in healthcare digital transformation and automation. Dominant trends anticipated during this time include the increasing use of AI-powered digital pathology platforms for precise disease detection, the broader deployment of cloud-based pathology data management systems for remote diagnostic purposes, the greater integration of deep learning models into histopathology image interpretation, the extension of automated slide scanning and digital workflow solutions within diagnostic laboratories, and a rising demand for AI-assisted clinical decision support systems in oncology and disease screening.
Download A Free Sample Report For Comprehensive Market Insights:
Artificial Intelligence (AI)-Powered Pathology Analysis System Market Industry Drivers: What Is Driving Revenue Growth?
The rising incidence of cancer is anticipated to propel the growth of the artificial intelligence (AI)-powered pathology analysis system market in the coming years. Cancer is a condition characterized by the uncontrolled multiplication of abnormal cells that can invade and spread to other bodily areas, originating in diverse tissues and organs and classified based on the cell or tissue type from which it arises. The increase in cancer cases is attributed to rising life expectancy, as the risk of developing the disease grows with age. AI-powered pathology analysis systems contribute to managing cancer incidence by automatically analyzing biopsy and tissue samples to detect, classify, and quantify cancerous cells, which enables faster and more accurate diagnosis and supports early detection of cancer cases. For instance, in August 2024, according to the Macmillan Cancer Support, a UK-based organization, more than 3 million people in the UK were living with cancer in 2024, and this figure was projected to increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the increasing prevalence of cancer is driving the expansion of the artificial intelligence (AI)-powered pathology analysis system market.
Artificial Intelligence (AI)-Powered Pathology Analysis System Market Segment Breakdown: Which Categories Generate The Most Revenue?
The artificial intelligence (AI)-powered pathology analysis system market covered in this report is segmented –
1) By Components: Software; Hardware; Services
2) By Technology: Machine Learning; Computer Vision; Natural Language Processing
3) By End User: Hospitals; Diagnostic Laboratories; Research Institutes; Pharmaceutical And Biotech Companies
Subsegments:
1) By Software: Image Analysis Software; Workflow Management Software; Data Management Software; Reporting And Visualization Software; Quality Control Software
2) By Hardware: Slide Scanners; Digital Microscopes; Servers And Storage Systems; High Performance Computing Systems; Imaging Devices
3) By Services: Installation And Integration Services; Maintenance And Support Services; Consulting Services; Training And Education Services; Data Analysis And Interpretation Services
Advanced AI-Driven Cancer Detection And Diagnostic Support In Digital Pathology
Major companies operating in the artificial intelligence (AI)-powered pathology analysis system market are focusing on developing advanced solutions, such as AI-driven cancer detection and diagnostic support platforms to enhance pathology workflow efficiency, improve diagnostic accuracy, accelerate clinical decision-making, and address the growing shortage of pathologists in healthcare systems. AI-driven cancer detection and diagnostic support platforms are software systems that use artificial intelligence to analyze medical data and images, helping healthcare professionals identify potential cancerous abnormalities and make more informed diagnostic decisions. For instance, in April 2025, Paige.AI Inc., a US-based healthcare technology company, has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for its AI application Paige PanCancer Detect, which is designed to assist pathologists in identifying cancerous regions across multiple tissue and organ types. The system uses advanced artificial intelligence to detect both common and rare cancer variants, helping improve diagnostic accuracy and reduce turnaround time in pathology workflows. It aims to address the increasing global shortage of pathologists by streamlining case screening and supporting faster clinical decision-making. This recognition highlights the growing role of AI in precision oncology and strengthens Paige’s position in developing regulatory-approved digital pathology solutions for improved cancer detection and patient care.
Artificial Intelligence (AI)-Powered Pathology Analysis System Market Key Players And Strategic Industry Positioning
Major companies operating in the artificial intelligence (AI)-powered pathology analysis system market are F. Hoffmann-La Roche Ltd.; Danaher Corporation; Koninklijke Philips N.V.; Hologic Inc.; Tempus AI Inc.; Owkin Inc.; OptraSCAN Inc.; Proscia Inc.; Tribun Health; 3DHISTECH Ltd.; Visiopharm A/S; Indica Labs Inc.; Ibex Medical Analytics Ltd.; Mindpeak GmbH; Aiosyn; DeepBio Inc.; AIRA Matrix Pvt. Ltd.; Aiforia Technologies Plc.; Lunit Inc.; Google Cloud
Access The Complete Artificial Intelligence (AI)-Powered Pathology Analysis System Market Report:
Artificial Intelligence (AI)-Powered Pathology Analysis System Market Regional Distribution: Which Areas Drive Market Expansion?
North America was the largest region in the artificial intelligence (AI)-powered pathology analysis system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-powered pathology analysis system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.